Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials

DOI: 10.2147/OTT.S192572

Keywords: sorafenib, hepatocellular carcinoma, randomized trial, biomarkers, erlotinib, linifanib, sunitinib, brivanib

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text